Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR at 75: A Diamond Jubilee

Vanessa Caceres  |  Issue: October 2009  |  October 1, 2009

The ACR also has witnessed enormous change in a short time period, Dr. Pisetsky says. “It started as a small organization during a tough time, and with primitive treatments,” he says. “I give the founders enormous credit for their vision and faith.”

At the time the organization began, rheumatic fever was a major challenge. Today, many problems faced 75 years ago are no longer problems. Instead, rheumatologists concentrate on more focused treatment questions for conditions such as RA, Dr. Pisetsky says. “We’ve made big advances in bone disease, but again, there are new questions. There are more public health questions now,” he says. “Any time you have a lot of success, there’s always the question of how you build on it.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Vanessa Caceres is a medical writer and editor in Florida.

Reference

  1. American Rheumatism Association. A 50-Year Retrospective, 1934–1984. ARA; 1984.

Page: 1 2 3 | Single Page
Share: 

Filed under:From the College Tagged with:2009 ACR/ARHP Annual Scientific MeetingACR NewsHistoryMethotrexateRheumatoid arthritis

Related Articles

    “The Pisetsky Effect”* Helps Mold The Rheumatologist into a Vibrant Publication

    December 12, 2011

    Colleagues and contributors share thoughts as the first editor’s tenure comes to a close

    Rheum After 5: Dr. David Pisetsky, Storyteller

    April 15, 2022

    David S. Pisetsky, MD, PhD, often tells people that science involves reading and writing as much as conducting experiments. No matter what discoveries are made in the lab, if they can’t be communicated well or put into context, he asks, how can they be used to advance the field and benefit patients? The recipient of…

    He Taught Us to Always Go Deeper

    March 18, 2011

    Eng Tan, MD, promotes translation from bench to bedside

    Reflections on a Diamond Celebration

    October 1, 2009

    Two former presidents discuss the ACR’s 75 years of progress

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences